• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Gold beats platinum for chemo drugs in new lab study

November 27, 2024
in Medical Research
Reading Time: 6 mins read
A A
0
Gold beats platinum for chemo drugs in new lab study
5
SHARES
10
VIEWS
Share on FacebookShare on Twitter


Gold beats platinum for chemo drugs in new lab study
Left: Normal cervical cancer cells with well-formed nuclei in blue and well-organized, elongated actin filaments—which play an essential role in cell survival and division—in green. Right: destabilized cervical cancer cells after gold compound treatment show structural integrity compromised while the nuclei in blue are breaking apart, indicating cell death. Credit: RMIT

A new gold-based drug can slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a study by Australian and Indian researchers.

The RMIT University study published in the European Journal of Medicinal Chemistry reveals a new gold-based compound that’s 27 times more potent against cervical cancer cells in the lab than standard chemotherapy drug cisplatin. It was also 3.5 times more effective against prostate cancer and 7.5 times more effective against fibrosarcoma cells in the lab.

In mice studies, the gold compound reduced cervical cancer tumor growth by 82%, compared to cisplatin’s 29%.

Project lead at RMIT, Distinguished Professor Suresh Bhargava AM, said it marked a promising step towards alternatives to platinum-based cancer drugs.

“These newly synthesized compounds demonstrate remarkable anticancer potential, outperforming current treatments in a number of significant aspects including their selectivity in targeting cancer cells,” said Bhargava, Director of RMIT’s Centre for Advanced Materials and Industrial Chemistry.

“While human trials are still a way off, we are really encouraged by these results.”

The gold-based compound is now protected by a US Patent and ready for further development towards potential clinical application.

Towards more targeted, less toxic treatment

Gold is famously known as the noblest of all metals because it has little or no reaction when encountering other substances; a property that makes it perfect for wedding rings and coins.

However, the gold compound used in this study is a chemically tailored form known as Gold(I), designed to be highly reactive and biologically active. This chemically reactive form was then tailored to interact with an enzyme abundant in cancer cells, known as thioredoxin reductase.

Gold beats platinum for chemo drugs in new lab study
RMIT Vice-Chancellor’s Research Fellow Dr. Ruchika Ojha synthesizing the gold anticancer drug in the lab. Credit: RMIT

By blocking this protein’s activity, the gold compound effectively shuts down cancer cells before they can multiply or develop drug resistance.

Bhargava said this highly targeted approach minimizes the toxic side effects seen with the platinum-based cisplatin, which targets DNA and damages both healthy and cancerous cells.

“Their selectivity in targeting cancer cells, combined with reduced systemic toxicity, points to a future where treatments are more effective and far less harmful,” Bhargava said.

This specific form of gold was also shown to be more stable than those used in earlier studies, allowing the compound to remain intact while reaching the tumor site.

Project co-lead at RMIT, Distinguished Professor Magdalena Plebanski, said along with this ability to block protein activity, the compound also had another weapon in its anti-cancer arsenal.

In zebrafish studies, it was shown to stop the formation of new blood vessels that tumors need in order to grow. This was the first time one of the team’s various gold compounds had shown this effect, known as anti-angiogenesis.

The drug’s effectiveness at using these two attacks simultaneously was demonstrated against a range of cancer cells. This included ovarian cancer cells, which are known to develop resistance to cisplatin treatment in many cases.

“Drug resistance is a significant challenge in cancer therapy,” said Plebanski, who heads RMIT’s Cancer, Ageing, and Vaccines Laboratory. “Seeing our gold compound have such strong efficacy against tough-to-treat ovarian cancer cells is an important step toward addressing recurrent cancers and metastases.”

Regional collaboration a key enabler

The dedicated RMIT team is collaborating with scientists at the Indian Institute of Chemical Technology (IICT) in Hyderabad. First author of the latest study, Dr. Srinivasa Reddy, was initially a graduate from RMIT’s joint Ph.D. program with IICT and is now playing an active role in the collaborative project.

Gold beats platinum for chemo drugs in new lab study
The 250 grams of pure Australian gold donated by Pallion subsidiary ABC Bullion to support the research. Credit: RMIT

Meanwhile, RMIT Vice-Chancellor’s Research Fellow Dr. Ruchika Ojha has been supporting Bhargava in building and leading his Molecular Engineering Group to continue advancing innovative research into gold-based therapeutics long into the future. “I am proud to carry forward Professor Bhargava’s golden legacy, ensuring his pioneering contributions to this field continue to inspire groundbreaking discoveries,” Ojha said.

Bhargava said leveraging the best minds and technical infrastructure across both Australia and India was critical to making a meaningful difference in the fight against cancer.

Gold has been a cornerstone of Indian Ayurvedic treatments for centuries, celebrated for its healing properties. Today, gold-based cancer treatments are gaining global traction, with advancements such as the repurposing of the anti-arthritic drug auranofin, now showing promise in clinical trials for oncology.

“We know that gold is readily accepted by the human body, and we know it has been used for thousands of years in treating various conditions,” Bhargava said.

“Essentially, gold has been market tested, but not scientifically validated. Our work is helping both provide the evidence base that’s missing, as well as delivering new families of molecules that are tailor-made to amplify the natural healing properties of gold,” he said.

Industry support worth its weight in gold

RMIT’s research in this field over a sustained period has caught the gold industry’s attention.

In October, Pallion subsidiary ABC Bullion committed an annual donation of 250 grams of pure Australian gold to support the research. Representatives of Canada’s third-largest gold producer, Agnico Eagle Mines, have also visited the RMIT labs to explore collaboration opportunities.

“These endorsements highlight the social and scientific impact of our research,” Bhargava said. “There is a recognition that this is not just a scientific breakthrough but a step towards addressing a global health challenge and people want to be a part of that.”

This project led by Bhargava and Pebanski brings together a dynamic team of young scientists including Dr. Srinivasa Reddy, Dr. Steven Priver, Dr. Ruchika Ojha, Dr. Ranjith Jakku, and Dr. Tayebeh Hosseinnejad. Meanwhile, six Ph.D. students from India, Germany, Australia, Bangladesh and Mexico have joined the effort, further strengthening the global collaboration.

More information:
T. Srinivasa Reddy et al, Gold(I) complexes of the type [AuL{κC-2-C6H4P(S)Ph2}] [L = PTA, PPh3, PPh2(C6H4-3-SO3Na) and PPh2(2-py)]: Synthesis, characterisation, crystal structures, and In Vitro and In Vivo anticancer properties, European Journal of Medicinal Chemistry (2024). DOI: 10.1016/j.ejmech.2024.117007

Provided by
RMIT University


Citation:
Gold beats platinum for chemo drugs in new lab study (2024, November 27)
retrieved 27 November 2024
from https://medicalxpress.com/news/2024-11-gold-platinum-chemo-drugs-lab.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Gold beats platinum for chemo drugs in new lab study
Left: Normal cervical cancer cells with well-formed nuclei in blue and well-organized, elongated actin filaments—which play an essential role in cell survival and division—in green. Right: destabilized cervical cancer cells after gold compound treatment show structural integrity compromised while the nuclei in blue are breaking apart, indicating cell death. Credit: RMIT

A new gold-based drug can slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a study by Australian and Indian researchers.

The RMIT University study published in the European Journal of Medicinal Chemistry reveals a new gold-based compound that’s 27 times more potent against cervical cancer cells in the lab than standard chemotherapy drug cisplatin. It was also 3.5 times more effective against prostate cancer and 7.5 times more effective against fibrosarcoma cells in the lab.

In mice studies, the gold compound reduced cervical cancer tumor growth by 82%, compared to cisplatin’s 29%.

Project lead at RMIT, Distinguished Professor Suresh Bhargava AM, said it marked a promising step towards alternatives to platinum-based cancer drugs.

“These newly synthesized compounds demonstrate remarkable anticancer potential, outperforming current treatments in a number of significant aspects including their selectivity in targeting cancer cells,” said Bhargava, Director of RMIT’s Centre for Advanced Materials and Industrial Chemistry.

“While human trials are still a way off, we are really encouraged by these results.”

The gold-based compound is now protected by a US Patent and ready for further development towards potential clinical application.

Towards more targeted, less toxic treatment

Gold is famously known as the noblest of all metals because it has little or no reaction when encountering other substances; a property that makes it perfect for wedding rings and coins.

However, the gold compound used in this study is a chemically tailored form known as Gold(I), designed to be highly reactive and biologically active. This chemically reactive form was then tailored to interact with an enzyme abundant in cancer cells, known as thioredoxin reductase.

Gold beats platinum for chemo drugs in new lab study
RMIT Vice-Chancellor’s Research Fellow Dr. Ruchika Ojha synthesizing the gold anticancer drug in the lab. Credit: RMIT

By blocking this protein’s activity, the gold compound effectively shuts down cancer cells before they can multiply or develop drug resistance.

Bhargava said this highly targeted approach minimizes the toxic side effects seen with the platinum-based cisplatin, which targets DNA and damages both healthy and cancerous cells.

“Their selectivity in targeting cancer cells, combined with reduced systemic toxicity, points to a future where treatments are more effective and far less harmful,” Bhargava said.

This specific form of gold was also shown to be more stable than those used in earlier studies, allowing the compound to remain intact while reaching the tumor site.

Project co-lead at RMIT, Distinguished Professor Magdalena Plebanski, said along with this ability to block protein activity, the compound also had another weapon in its anti-cancer arsenal.

In zebrafish studies, it was shown to stop the formation of new blood vessels that tumors need in order to grow. This was the first time one of the team’s various gold compounds had shown this effect, known as anti-angiogenesis.

The drug’s effectiveness at using these two attacks simultaneously was demonstrated against a range of cancer cells. This included ovarian cancer cells, which are known to develop resistance to cisplatin treatment in many cases.

“Drug resistance is a significant challenge in cancer therapy,” said Plebanski, who heads RMIT’s Cancer, Ageing, and Vaccines Laboratory. “Seeing our gold compound have such strong efficacy against tough-to-treat ovarian cancer cells is an important step toward addressing recurrent cancers and metastases.”

Regional collaboration a key enabler

The dedicated RMIT team is collaborating with scientists at the Indian Institute of Chemical Technology (IICT) in Hyderabad. First author of the latest study, Dr. Srinivasa Reddy, was initially a graduate from RMIT’s joint Ph.D. program with IICT and is now playing an active role in the collaborative project.

Gold beats platinum for chemo drugs in new lab study
The 250 grams of pure Australian gold donated by Pallion subsidiary ABC Bullion to support the research. Credit: RMIT

Meanwhile, RMIT Vice-Chancellor’s Research Fellow Dr. Ruchika Ojha has been supporting Bhargava in building and leading his Molecular Engineering Group to continue advancing innovative research into gold-based therapeutics long into the future. “I am proud to carry forward Professor Bhargava’s golden legacy, ensuring his pioneering contributions to this field continue to inspire groundbreaking discoveries,” Ojha said.

Bhargava said leveraging the best minds and technical infrastructure across both Australia and India was critical to making a meaningful difference in the fight against cancer.

Gold has been a cornerstone of Indian Ayurvedic treatments for centuries, celebrated for its healing properties. Today, gold-based cancer treatments are gaining global traction, with advancements such as the repurposing of the anti-arthritic drug auranofin, now showing promise in clinical trials for oncology.

“We know that gold is readily accepted by the human body, and we know it has been used for thousands of years in treating various conditions,” Bhargava said.

“Essentially, gold has been market tested, but not scientifically validated. Our work is helping both provide the evidence base that’s missing, as well as delivering new families of molecules that are tailor-made to amplify the natural healing properties of gold,” he said.

Industry support worth its weight in gold

RMIT’s research in this field over a sustained period has caught the gold industry’s attention.

In October, Pallion subsidiary ABC Bullion committed an annual donation of 250 grams of pure Australian gold to support the research. Representatives of Canada’s third-largest gold producer, Agnico Eagle Mines, have also visited the RMIT labs to explore collaboration opportunities.

“These endorsements highlight the social and scientific impact of our research,” Bhargava said. “There is a recognition that this is not just a scientific breakthrough but a step towards addressing a global health challenge and people want to be a part of that.”

This project led by Bhargava and Pebanski brings together a dynamic team of young scientists including Dr. Srinivasa Reddy, Dr. Steven Priver, Dr. Ruchika Ojha, Dr. Ranjith Jakku, and Dr. Tayebeh Hosseinnejad. Meanwhile, six Ph.D. students from India, Germany, Australia, Bangladesh and Mexico have joined the effort, further strengthening the global collaboration.

More information:
T. Srinivasa Reddy et al, Gold(I) complexes of the type [AuL{κC-2-C6H4P(S)Ph2}] [L = PTA, PPh3, PPh2(C6H4-3-SO3Na) and PPh2(2-py)]: Synthesis, characterisation, crystal structures, and In Vitro and In Vivo anticancer properties, European Journal of Medicinal Chemistry (2024). DOI: 10.1016/j.ejmech.2024.117007

Provided by
RMIT University


Citation:
Gold beats platinum for chemo drugs in new lab study (2024, November 27)
retrieved 27 November 2024
from https://medicalxpress.com/news/2024-11-gold-platinum-chemo-drugs-lab.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

White House presses Ukraine to lower draft age to meet manpower needs against Russia

Next Post

Wolverine Asset Management sells $2.28 million in integrated rail stock By Investing.com todayheadline

Related Posts

Autism and ADHD have distinct brain connectivity signatures, study finds

Autism and ADHD have distinct brain connectivity signatures, study finds

May 31, 2025
8

Journalists Draw Link Between Internet Dead Zones, Threatened Medicaid Cuts, and Health

May 31, 2025
8
Next Post
Hyperscale data's executive chairman Milton Ault buys $564 in stock By Investing.com

Wolverine Asset Management sells $2.28 million in integrated rail stock By Investing.com todayheadline

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
The Straits Times logo

Korea’s presidential front runner Lee Jae-myung backs nuclear power — for now

June 1, 2025
South Korea’s snap presidential election 2025: All you need to know

South Korea’s snap presidential election 2025: All you need to know

June 1, 2025
Calgary police to deploy enhanced security measures during busy street festival season

Calgary police to deploy enhanced security measures during busy street festival season

June 1, 2025
France, Saudi Arabia seek spotlight in pushing for two state solution

France, Saudi Arabia seek spotlight in pushing for two state solution

June 1, 2025

Recent News

The Straits Times logo

Korea’s presidential front runner Lee Jae-myung backs nuclear power — for now

June 1, 2025
4
South Korea’s snap presidential election 2025: All you need to know

South Korea’s snap presidential election 2025: All you need to know

June 1, 2025
2
Calgary police to deploy enhanced security measures during busy street festival season

Calgary police to deploy enhanced security measures during busy street festival season

June 1, 2025
3
France, Saudi Arabia seek spotlight in pushing for two state solution

France, Saudi Arabia seek spotlight in pushing for two state solution

June 1, 2025
4

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

The Straits Times logo

Korea’s presidential front runner Lee Jae-myung backs nuclear power — for now

June 1, 2025
South Korea’s snap presidential election 2025: All you need to know

South Korea’s snap presidential election 2025: All you need to know

June 1, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co